Medical Device Regulatory Market Access in Times of a National Emergency

Hosted by the University of Illinois, this special webinar was developed to explain what non-medical manufacturers need to know to help alleviate supply shortages of critically needed medical devices in response to the COVID-19 pandemic. Featuring experts from both Emergo by UL and UL LLC, this session addresses a timely issue and will be of interest far beyond the medical device industry.

Presenters:

Audrey Swearingen, Regulatory Affairs Manager | Emergo by UL
Michael Wiklund, General Manager - Human Factors Research & Design | Emergo by UL
James Benscoter, Senior Staff Engineer | UL LLC
Anura Fernando, Chief Innovation Architect – Medical Systems Interoperability and Security | UL LLC

Search form

FDA asks COVID test makers to switch from emergency to premarket approvals

Singapore’s HSA to commence Phase I implementation of UDI labeling in November 2022

Software as a Medical Device (SaMD): EU/US Regulatory Considerations

Scaling and Conducting Use-Related Risk Analysis (URRA)

Search form

Medical Device Regulatory Market Access in Times of a National Emergency

Questions? Request more information from our specialists

Have questions on what Emergo can do for you?

© 2022 EMERGO by UL. All Rights Reserved. Privacy Terms of Use Data Subject Access Request Portal

FDA asks COVID test makers to switch from emergency to premarket approvals

Singapore’s HSA to commence Phase I implementation of UDI labeling in November 2022

Types

Related Service

Software as a Medical Device (SaMD): EU/US Regulatory Considerations

Scaling and Conducting Use-Related Risk Analysis (URRA)

Medical Device Regulatory Market Access in Times of a National Emergency

Questions? Request more information from our specialists

Related

Developing Effective Training to Enhance and Support Internal HFE Resources

Early Communication with the FDA

Have questions on what Emergo can do for you?